Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug discovery today.

Oliver Schwardt1, Hartmuth Kolb, Beat Ernst

  • 1Institute of Molecular Pharmacy, Pharmacenter, University of Basel, Klingelbergstrasse 50, Switzerland.

Current Topics in Medicinal Chemistry
|February 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Analogs of the Compstatin Family of Clinical Complement Inhibitors with Low Picomolar Target Affinity.

Journal of medicinal chemistry·2026
Same author

Design, synthesis and biophysical evaluation of sialyl triazoles as glycomimetic ligands for Siglec-8. Sulfonate is a viable replacement for sulfate.

European journal of medicinal chemistry·2026
Same author

Acid Versus Amide-Facts and Fallacies: A Case Study in Glycomimetic Ligand Design.

Molecules (Basel, Switzerland)·2025
Same author

Glycopolymer binds pathogenic IgM autoantibodies and pulls them into the mononuclear phagocyte system for degradation.

Scientific reports·2025
Same author

Plasma biomarkers, brain amyloid-beta pathology, and cortical thickness in a non-Hispanic White and Black/African American middle-aged community cohort: The HCP-CoBRA study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studies.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
Same journal

Inhibitory Effects of Flavonoids from the Stems and Leaves of Scutellaria baicalensis Georgi on Oligodendrocyte Pyroptosis Induced by Aβ1-42.

Current topics in medicinal chemistry·2026
Same journal

Mechanism of Huangqishihu Decoction in Treating Liver Fibrosis in Rats Model via Regulation of Oxidative Stress and Nrf2 Signaling Pathway.

Current topics in medicinal chemistry·2026
See all related articles

Advancements in drug discovery, including high throughput screening and in silico methods, accelerate lead identification and optimization. Novel NMR screening techniques offer new opportunities for faster drug development and reduced failure rates.

Area of Science:

  • Drug discovery and development
  • Medicinal chemistry
  • Biotechnology

Background:

  • Drug development faces challenges with high failure rates and lengthy timelines.
  • Technological advancements in genomics, proteomics, and biophysics have improved drug discovery tools.
  • Early ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) studies are crucial for reducing candidate failure.

Purpose of the Study:

  • To review novel screening methods, particularly those utilizing NMR (Nuclear Magnetic Resonance), for drug discovery.
  • To highlight how these methods enhance lead finding and lead optimization.
  • To discuss the impact of these advancements on the speed and efficiency of drug development.

Main Methods:

  • High throughput screening (HTS) for accelerating compound library evaluation.

Related Experiment Videos

  • In silico screening for assessing virtual compounds.
  • Novel screening methodologies employing NMR spectroscopy.

    • Main Results:

    • HTS has dramatically accelerated the screening of single compounds and libraries.
    • In silico methods enable the evaluation of virtual compound libraries.
    • NMR-based screening methods provide a wide range of new opportunities for lead identification and optimization.

    Conclusions:

    • Technological improvements have significantly enhanced drug discovery speed and efficiency.
    • Outsourcing drug discovery research to biotech companies is an increasing trend.
    • Novel screening methods, especially NMR-based approaches, are key to overcoming drug development challenges and achieving a faster time to market.